|
1
|
Durante M and Loeffler JS: Charged
particles in radiation oncology. Nat Rev Clin Oncol. 7:37–43. 2010.
View Article : Google Scholar
|
|
2
|
Suit H, DeLaney T, Goldberg S, Paganetti
H, Clasie B, Gerweck L, Niemierko A, Hall E, Flanz J, Hallman J and
Trofimov A: Proton vs carbon ion beams in the definitive radiation
treatment of cancer patients. Radiother Oncol. 95:3–22. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weyrather WK and Debus J: Particle beams
for cancer therapy. Clin Oncol (R Coll Radiol). 15:S23–S28. 2003.
View Article : Google Scholar
|
|
4
|
Hamada N: Recent insights into the
biological action of heavy-ion radiation. J Radiat Res. 50:1–9.
2009. View Article : Google Scholar
|
|
5
|
PTCOG Patient Statistics: Particle Therapy
Co-Operative Group (PTCOG), Villigen 2016. https://www.ptcog.ch/index.php/ptcog-patient-statistics.
|
|
6
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Corbin K and Mutter R: Proton therapy for
breast cancer: Progress & pitfalls. Breast Cancer Management.
7:2018. View Article : Google Scholar
|
|
8
|
Menezes KM, Wang H, Hada M and Saganti PB:
Radiation matters of the heart: A mini review. Front Cardiovasc
Med. 5:832018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akamatsu H, Karasawa K, Omatsu T, Isobe Y,
Ogata R and Koba Y: First experience of carbon-ion radiotherapy for
early breast cancer. Jpn J Radiol. 32:288–295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weber DC, Abrunhosa-Branquinho A, Bolsi A,
Kacperek A, Dendale R, Geismar D, Bachtiary B, Hall A, Heufelder J,
Herfarth K, et al: Profile of European proton and carbon ion
therapy centers assessed by the EORTC facility questionnaire.
Radiother Oncol. 124:185–189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lorusso G and Rüegg C: New insights into
the mechanisms of organ-specific breast cancer metastasis. Semin
Cancer Biol. 22:226–233. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nicolini A, Giardino R, Carpi A, Ferrari
P, Anselmi L, Colosimo S, Conte M, Fini M, Giavaresi G, Berti P and
Miccoli P: Metastatic breast cancer: An updating. Biomed
Pharmacother. 60:548–556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karhadkar SS, Bova GS, Abdallah N, Dhara
S, Gardner D, Maitra A, Isaacs JT, Berman DM and Beachy PA:
Hedgehog signalling in prostate regeneration, neoplasia and
metastasis. Nature. 431:707–712. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gonnissen A, Isebaert S and Haustermans K:
Hedgehog signaling in prostate cancer and its therapeutic
implication. Int J Mol Sci. 14:13979–14007. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kubo M, Nakamura M, Tasaki A, Yamanaka N,
Nakashima H, Nomura M, Kuroki S and Katano M: Hedgehog signaling
pathway is a new therapeutic target for patients with breast
cancer. Cancer Res. 64:6071–6074. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Toole SA, Machalek DA, Shearer RF,
Millar EK, Nair R, Schofield P, McLeod D, Cooper CL, McNeil CM,
McFarland A, et al: Hedgehog overexpression is associated with
stromal interactions and predicts for poor outcome in breast
cancer. Cancer Res. 71:4002–4014. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui W, Wang LH, Wen YY, Song M, Li BL,
Chen XL, Xu M, An SX, Zhao J, Lu YY, et al: Expression and
regulation mechanisms of sonic hedgehog in breast cancer. Cancer
Sci. 101:927–933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang L, Zhao D, Liu HB, Wang QS, Zhang P,
Li CL, Du WZ, Wang HJ, Liu X, Zhang ZR and Jiang CL: Activation of
sonic hedgehog signaling enhances cell migration and invasion by
induction of matrix metalloproteinase-2 and -9 via the
phos-phoinositide-3 kinase/AKT signaling pathway in glioblastoma.
Mol Med Rep. 12:6702–6710. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Q, Gao G and Luo S: Hedgehog
signaling pathway and ovarian cancer. Chin J Cancer Res.
25:346–353. 2013.PubMed/NCBI
|
|
20
|
Yan R, Peng X, Yuan X, Huang D, Chen J, Lu
Q, Lv N and Luo S: Suppression of growth and migration by blocking
the hedgehog signaling pathway in gastric cancer cells. Cell Oncol
(Dordr). 36:421–435. 2013. View Article : Google Scholar
|
|
21
|
Feldmann G, Dhara S, Fendrich V, Bedja D,
Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio-Donahue C,
Jimeno A, et al: Blockade of hedgehog signaling inhibits pancreatic
cancer invasion and metastases: A new paradigm for combination
therapy in solid cancers. Cancer Res. 67:2187–2196. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Isohata N, Aoyagi K, Mabuchi T, Daiko H,
Fukaya M, Ohta H, Ogawa K, Yoshida T and Sasaki H: Hedgehog and
epithelial-mesen-chymal transition signaling in normal and
malignant epithelial cells of the esophagus. Int J Cancer.
125:1212–1221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK,
Kim HK, Kim JS and Oh SC: Sonic hedgehog pathway promotes
metastasis and lymphangiogenesis via activation of Akt, EMT, and
MMP-9 pathway in gastric cancer. Cancer Res. 71:7061–7070. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin Z, Li S, Sheng H, Cai M, Ma LY, Hu L,
Xu S, Yu LS and Zhang N: Suppression of GLI sensitises
medulloblastoma cells to mitochondria-mediated apoptosis. J Cancer
Res Clin Oncol. 142:2469–2478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Q, Xu R, Zeng C, Lu Q, Huang D, Shi
C, Zhang W, Deng L, Yan R, Rao H, et al: Down-regulation of Gli
transcription factor leads to the inhibition of migration and
invasion of ovarian cancer cells via integrin β4-mediated FAK
signaling. PLoS One. 9:e883862014. View Article : Google Scholar
|
|
26
|
Magistri P, Battistelli C, Strippoli R,
Petrucciani N, Pellinen T, Rossi L, Mangogna L, Aurello P, D'Angelo
F, Tripodi M, et al: SMO inhibition modulates cellular plasticity
and invasiveness in colorectal cancer. Front Pharmacol. 8:9562018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yue D, Li H, Che J, Zhang Y, Tseng HH, Jin
JQ, Luh TM, Giroux-Leprieur E, Mo M, Zheng Q, et al: Hedgehog/Gli
promotes epithelial-mesenchymal transition in lung squamous cell
carcinomas. J Exp Clin Cancer Res. 33:342014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng J, Aziz K, Chettiar ST, Aftab BT,
Armour M, Gajula R, Gandhi N, Salih T, Herman JM, Wong J, et al:
Hedgehog pathway inhibition radiosensitises non-small cell lung
cancers. Int J Radiat Oncol Biol Phys. 86:143–149. 2013. View Article : Google Scholar
|
|
29
|
Gonnissen A, Isebaert S, McKee CM, Dok R,
Haustermans K and Muschel RJ: The hedgehog inhibitor GANT61
sensitises prostate cancer cells to ionizing radiation both in
vitro and in vivo. Oncotarget. 7:84286–84298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Teichman J, Dodbiba L, Thai H, Fleet A,
Morey T, Liu L, McGregor M, Cheng D, Chen Z, Darling G, et al:
Hedgehog inhibition mediates radiation sensitivity in mouse
xenograft models of human esophageal adenocarcinoma. PLoS One.
13:e01948092018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsai CL, Hsu FM, Tzen KY, Liu WL, Cheng AL
and Cheng JC: Sonic Hedgehog inhibition as a strategy to augment
radiosensitivity of hepatocellular carcinoma. J Gastroenterol
Hepatol. 30:1317–1324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Franco AI, Eastwick G, Farah R, Heyboer M,
Lee M and Aridgides P: Upfront radiotherapy with concurrent and
adjuvant vismodegib is effective and well-tolerated in a patient
with advanced, multifocal basal cell carcinoma. Case Rep Dermatol
Med. 2018:23541462018.PubMed/NCBI
|
|
33
|
Schulze B, Meissner M, Ghanaati S, Burck
I, Rodel C and Balermpas P: Hedgehog pathway inhibitor in
combination with radiation therapy for basal cell carcinomas of the
head and neck: First clinical experience with vismodegib for
locally advanced disease. Strahlenther Onkol. 192:25–31. 2016.
View Article : Google Scholar
|
|
34
|
Pollom EL, Bui TT, Chang AL, Colevas AD
and Hara WY: Concurrent vismodegib and radiotherapy for recurrent,
advanced basal cell carcinoma. JAMA Dermatol. 151:998–1001. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Raleigh DR, Algazi A, Arron ST, Neuhaus IM
and Yom SS: Induction hedgehog pathway inhibition followed by
combined-modality radiotherapy for basal cell carcinoma. Br J
Dermatol. 173:544–546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Atwood SX, Chang AL and Oro AE: Hedgehog
pathway inhibition and the race against tumor evolution. J Cell
Biol. 199:193–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rudin CM, Hann CL, Laterra J, Yauch RL,
Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, et
al: Treatment of medulloblastoma with hedgehog pathway inhibitor
GDC-0449. N Engl J Med. 361:1173–1178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chang AL and Oro AE: Initial assessment of
tumor regrowth after vismodegib in advanced Basal cell carcinoma.
Arch Dermatol. 148:1324–1325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gonnissen A, Isebaert S, McKee CM, Muschel
RJ and Haustermans K: The effect of metformin and GANT61
combinations on the radiosensitivity of prostate cancer cells. Int
J Mol Sci. 18:E3992017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou J, Wu K, Gao D, Zhu G, Wu D, Wang X,
Chen Y, Du Y, Song W, Ma Z, et al: Reciprocal regulation of
hypoxia-inducible factor 2α and GLI1 expression associated with the
radioresis-tance of renal cell carcinoma. Int J Radiat Oncol Biol
Phys. 90:942–951. 2014. View Article : Google Scholar
|
|
41
|
Lesueur P, Chevalier F, El-Habr EA, Junier
MP, Chneiweiss H, Castera L, Muller E, Stefan D and Saintigny Y:
Radiosensitization effect of talazoparib, a parp inhibitor, on
glioblastoma stem cells exposed to low and high linear energy
transfer radiation. Sci Rep. 8:36642018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Soule HD, Vazguez J, Long A, Albert S and
Brennan M: A human cell line from a pleural effusion derived from a
breast carcinoma. J Natl Cancer Inst. 51:1409–1416. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Durantel F, Balanzat E, Cassimi A,
Chevalier F, Ngono-Ravache Y, Madi T, Poully JC, Ramillon JM,
Rothard H, Ropars F, et al: Dosimetry for radiobiology experiments
at GANIL. Nuclear instruments and methods in physics research
section A: Accelerators, Spectrometers, Detectors and Associated
Equipment. Elsevier. 816:70–77. 2016.
|
|
44
|
Suetens A, Moreels M, Quintens R, Soors E,
Buset J, Chiriotti S, Tabury K, Gregoire V and Baatout S: Dose- and
time-dependent gene expression alterations in prostate and colon
cancer cells after in vitro exposure to carbon ion and
X-irradiation. J Radiat Res. 56:11–21. 2015. View Article : Google Scholar :
|
|
45
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Moncharmont C, Levy A, Guy JB, Falk AT,
Guilbert M, Trone JC, Alphonse G, Gilormini M, Ardail D, Toillon
RA, et al: Radiation-enhanced cell migration/invasion process: A
review. Crit Rev Oncol Hematol. 92:133–142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fujita M, Imadome K, Shoji Y, Isozaki T,
Endo S, Yamada S and Imai T: Carbonion irradiation suppresses
migration and invasiveness of human pancreatic carcinoma cells
MIAPaCa-2 via Rac1 and RhoA degradation. Int J Radiat Oncol Biol
Phys. 93:173–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fujita M, Yamada S and Imai T: Irradiation
induces diverse changes in invasive potential in cancer cell lines.
Semin Cancer Biol. 35:45–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Matsumoto Y, Furusawa Y, Uzawa A, Hirayama
R, Koike S, Ando K, Tsuboi K and Sakurai H: Antimetastatic effects
of carbon-ion beams on malignant melanomas. Radiat Res.
190:412–423. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang X, Li X, Zhang N, Yang Q and Moran
MS: Low doses ionizing radiation enhances the invasiveness of
breast cancer cells by inducing epithelial-mesenchymal transition.
Biochem Biophys Res Commun. 412:188–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chapman JD, Doern SD, Reuvers AP,
Gillespie CJ, Chatterjee A, Blakely EA, Smith KC and Tobias CA:
Radioprotection by DMSO of mammalian cells exposed to X-rays and to
heavy charged-particle beams. Radiat Environ Biophys. 16:29–41.
1979. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Goddu SM, Narra VR, Harapanhalli RS,
Howell RW and Rao DV: Radioprotection by DMSO against the
biological effects of incorporated radionuclides in vivo-Comparison
with other radioprotectors and evidence for indirect action of
Auger electrons. Acta Oncol. 35:901–907. 1996. View Article : Google Scholar
|
|
54
|
Fushimi K, Uzawa K, Ishigami T, Yamamoto
N, Kawata T, Shibahara T, Ito H, Mizoe JE, Tsujii H and Tanzawa H:
Susceptible genes and molecular pathways related to heavy ion
irradiation in oral squamous cell carcinoma cells. Radiother Oncol.
89:237–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kamlah F, Hänze J, Arenz A, Seay U, Hasan
D, Juricko J, Bischoff B, Gottschald OR, Fournier C, Taucher-Scholz
G, et al: Comparison of the effects of carbon ion and photon
irradiation on the angiogenic response in human lung adenocarcinoma
cells. Int J Radiat Oncol Biol Phys. 80:1541–1549. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gan GN, Eagles J, Keysar SB, Wang G,
Glogowska MJ, Altunbas C, Anderson RT, Le PN, Morton JJ, Frederick
B, et al: Hedgehog signaling drives radioresistance and
stroma-driven tumor repopulation in head and neck squamous cancers.
Cancer Res. 74:7024–7036. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Suetens A, Moreels M, Quintens R,
Chiriotti S, Tabury K, Michaux A, Gregoire V and Baatout S: Carbon
ion irradiation of the human prostate cancer cell line PC3: A whole
genome microarray study. Int J Oncol. 44:1056–1072. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhou X, Zhang X, Xie Y, Tanaka K, Wang B
and Zhang H: DNA-PKcs inhibition sensitises cancer cells to
carbon-ion irradiation via telomere capping disruption. PLoS One.
8:e726412013. View Article : Google Scholar
|
|
59
|
Sai S, Vares G, Kim EH, Karasawa K, Wang
B, Nenoi M, Horimoto Y and Hayashi M: Carbon ion beam combined with
cisplatin effectively disrupts triple negative breast cancer
stem-like cells in vitro. Mol Cancer. 14:1662015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Suzuki M, Kase Y, Yamaguchi H, Kanai T and
Ando K: Relative biological effectiveness for cell-killing effect
on various human cell lines irradiated with heavy-ion medical
accelerator in Chiba (HIMAC) carbon-ion beams. Int J Radiat Oncol
Biol Phys. 48:241–250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wada M, Suzuki M, Liu C, Kaneko Y, Fukuda
S, Ando K and Matsufuji N: Modeling the biological response of
normal human cells, including repair processes, to fractionated
carbon beam irradiation. J Radiat Res. 54:798–807. 2013. View Article : Google Scholar : PubMed/NCBI
|
